Lindenwold Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,289
Closed -$1.21M 114
2023
Q2
$1.21M Sell
7,289
-1,068
-13% -$172K 0.74% 46
2023
Q1
$1.3M Buy
8,357
+118
+1% +$19.1K 0.8% 44
2022
Q4
$1.46M Buy
8,239
+96
+1% +$16.6K 0.98% 38
2022
Q3
$1.33M Sell
8,143
-41
-0.5% -$6.94K 0.98% 38
2022
Q2
$1.45M Buy
8,184
+141
+2% +$25.1K 1.03% 37
2022
Q1
$1.43M Sell
8,043
-711
-8% -$121K 0.87% 40
2021
Q4
$1.5M Buy
+8,754
New +$1.43M 0.87% 40

Other funds holding JNJ

Lindenwold Advisors's JNJ Position: Q3 2023 in Review

Lindenwold Advisors sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 7,289 shares — an estimated $1.21M sold.

Lindenwold Advisors first reported a position in JNJ in Q4 2021 and held it in 7 quarters. The position peaked at $1.5M in Q4 2021. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Lindenwold Advisors reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • Lindenwold Advisors sold 7,289 Johnson & Johnson shares in Q3 2023, an estimated $1.21M.
  • Lindenwold Advisors first reported a position in Johnson & Johnson in Q4 2021 and held it in 7 quarters.
  • Lindenwold Advisors's Johnson & Johnson position peaked at $1.5M in Q4 2021.
  • 3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Lindenwold Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.